FDA Brief: Week of Feb 15, 2016

biosimilar

WHAT: Continuing Education Course for health care professionals  to strengthen knowledge and understanding of biosimilars and interchangeable products – which are not generic products

WHY: Growing interest in biosimilars and interchangeable products in the pharmaceutical industry

HOW: Will inform about the development process, approval pathways, and  relationships between biosimilars and interchangeable products.

LINK

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s